Showing results (281-290 of 1,149) with videos related to
Sort By:
Pageof 115
Clinical Pharmacokinetics|March 1, 1988
Clinical pharmacokinetics of urapidilR Kirsten, K Nelson, V W Steinijans, et al.Molecular and Cellular Biology|August 1, 1995
The phosphotyrosine interaction domain of Shc binds an LXNPXY motif on the epidermal growth factor receptorA G Batzer, P Blaikie, K Nelson, et al.Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|February 1, 1993
Home nutrition support patient education materialsM A Evans, T K Liffrig, J K Nelson, et al.The Journal of Experimental Medicine|November 1, 1991
Characterization and clonal distribution of four alleles of the speA gene encoding pyrogenic exotoxin A (scarlet fever toxin) in Streptococcus pyogenesK Nelson, P M Schlievert, R K Selander, et al.Journal of Cognitive Neuroscience|June 1, 2007
Age differences in deactivation: a link to cognitive control?Jonas Persson, Cindy Lustig, James K Nelson, et al.Neurosurgery|October 21, 2006
Endovascular treatment of spinal cord arteriovenous malformationsErol Veznedaroglu, Peter K Nelson, Pascal M Jabbour, et al.International Journal of Obesity|December 1, 1990
Interdigestive cycling and post-prandial release of pancreatic polypeptide in severe obesityO Pieramico, P Malfertheiner, D K Nelson, et al.Tetrahedron Letters|October 9, 2009
The catalytic asymmetric addition of alkyl- and aryl-zinc reagents to an isoxazole aldehydeJared K Nelson, Brendan Twamley, Trinidad J Villalobos, et al.Journal of the American Veterinary Medical Association|July 15, 1988
Toxicity of a vitamin D3 rodenticide to dogsR Gunther, L J Felice, R K Nelson, et al.Proceedings of the National Academy of Sciences of the United States of America|June 1, 1980
Studies on the mechanism of skin tumor promotion: evidence for several stages in promotionT J Slaga, S M Fischer, K Nelson, et al.Pageof 115